SCHEMBL29872415

SCHEMBL29872415

COc1ccc(CN(Cc2ccc(OC)cc2)c2nn(Cc3ccc(OC)cc3)c3ncc(N)cc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE1B Q01064 7/20 0.40
▸ LMNA P02545 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ALOX15 P16050 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ PDE5A O76074 1/20 0.38
▸ NPBWR1 P48145 3/20 0.38
▸ PDE1A P54750 1/20 0.38
▸ PDE1C Q14123 1/20 0.38
▸ NOS1 P29475 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29872467 0.86 ALDH1A1 (0.46) PDE1BLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1593023 0.82 CNR1 (0.47) PDE1BLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL29873266 0.82 MAPT (0.45) PDE1BMAPTSMN1; SMN2CNR1CNR2
SCHEMBL1593160 0.81 MAPT (0.43) PDE1BLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1593142 0.80 CNR1 (0.47) PDE1BLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1594020 0.78 CNR1 (0.46) PDE1BLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL29873567 0.76 MAPT (0.44) LMNAMAPTALDH1A1SMN1; SMN2ALOX15
SCHEMBL16536772 0.75 PDE1B (0.53) PDE1BLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL4935801 0.75 CNR1 (0.43) PDE1BLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1593833 0.74 CNR2 (0.42) PDE1BLMNAMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220306640-A1 HYDANTOIN DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2022-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306640-A1 HYDANTOIN DERIVATIVE DDR1, DDR2, DDRGK1 PDE1B 1600/4885LMNA 1274/4885MAPT 3943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback